Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Introduction.

March L, Richards B, Gill M, Brooks PM, Shea BJ, Beaton DE, Maxwell LJ, Tunis SR, Grosskleg S, Tugwell P.

J Rheumatol. 2019 Aug;46(8):962-968. doi: 10.3899/jrheum.190105. No abstract available.

PMID:
31371663
2.

Consensus Building in OMERACT: Recommendations for Use of the Delphi for Core Outcome Set Development.

Humphrey-Murto S, Crew R, Shea B, Bartlett SJ, March L, Tugwell P, Maxwell LJ, Beaton D, Grosskleg S, de Wit M.

J Rheumatol. 2019 Aug;46(8):1041-1046. doi: 10.3899/jrheum.181094. Epub 2019 Feb 15.

PMID:
30770512
3.

Core Domain Set Selection According to OMERACT Filter 2.1: The OMERACT Methodology.

Maxwell LJ, Beaton DE, Shea BJ, Wells GA, Boers M, Grosskleg S, Bingham CO 3rd, Conaghan PG, D'Agostino MA, de Wit M, Gossec L, March L, Simon LS, Singh JA, Strand V, Tugwell P.

J Rheumatol. 2019 Aug;46(8):1014-1020. doi: 10.3899/jrheum.181097. Epub 2019 Feb 15.

PMID:
30770502
4.

Instrument Selection Using the OMERACT Filter 2.1: The OMERACT Methodology.

Beaton DE, Maxwell LJ, Shea BJ, Wells GA, Boers M, Grosskleg S, Bingham CO 3rd, Conaghan PG, D'Agostino MA, de Wit MP, Gossec L, March LM, Simon LS, Singh JA, Strand V, Tugwell P.

J Rheumatol. 2019 Aug;46(8):1028-1035. doi: 10.3899/jrheum.181218. Epub 2019 Feb 1.

PMID:
30709952
5.

Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT Premeeting Toward Consensus on Core Sets for Randomized Controlled Trials.

Andersen KM, Cheah JTL, March L, Bartlett SJ, Beaton D, Bingham CO 3rd, Brooks PM, Christensen R, Conaghan PG, D'Agostino MA, de Wit M, Dueck AC, Goodman SM, Grosskleg S, Hill CL, Howell M, Mackie SL, Richards B, Shea B, Singh JA, Strand V, Tugwell P, Wells GA, Simon LS.

J Rheumatol. 2019 Aug;46(8):1053-1058. doi: 10.3899/jrheum.181123. Epub 2019 Jan 15.

PMID:
30647191
6.

The Third Biennial 2018 OMERACT First-time Participant Program: A Qualitative and Quantitative Study.

Sloan VS, Grosskleg S, Wells G, Singh JA.

J Rheumatol. 2019 Aug;46(8):1036-1040. doi: 10.3899/jrheum.181196. Epub 2019 Jan 15.

PMID:
30647187
7.

Introduction.

Tugwell P, Grosskleg S, Shea B, Beaton D, Wells GA.

J Rheumatol. 2017 Oct;44(10):1511-1514. doi: 10.3899/jrheum.170659. No abstract available.

PMID:
28966171
8.

The OMERACT First-time Participant Program: Fresh Eye from the New Guys.

Sloan VS, Grosskleg S, Pohl C, Wells GA, Singh JA.

J Rheumatol. 2017 Oct;44(10):1560-1563. doi: 10.3899/jrheum.161119. Epub 2017 May 15.

PMID:
28507185
9.

Current State of Reporting Pain Outcomes in Cochrane Reviews of Chronic Musculoskeletal Pain Conditions and Considerations for an OMERACT Research Agenda.

Maxwell LJ, Wells GA, Simon LS, Conaghan PG, Grosskleg S, Scrivens K, Beaton DE, Bingham CO 3rd, Busse JW, Christensen R, Goel N, J√ľni P, Kaiser U, Lyddiatt A, Mease PJ, Ostelo RW, Phillips K, Sapunar D, Singh JA, Strand V, Taylor AM, Terwee CB, Tugwell P.

J Rheumatol. 2015 Oct;42(10):1934-1942. doi: 10.3899/jrheum.141423. Epub 2015 Sep 15.

10.

The Spirit of OMERACT: Q Methodology Analysis of Conference Characteristics Valued by Delegates.

Flurey CA, Kirwan JR, Hadridge P, Richards P, Grosskleg S, Tugwell PS.

J Rheumatol. 2015 Oct;42(10):1982-1992. doi: 10.3899/jrheum.150113. Epub 2015 Aug 15.

PMID:
26276970
11.

The OMERACT First-time Participant ("Newbie") Program: Initial Assessment and Lessons Learned.

Sloan VS, Grosskleg S, Pohl C, Wells GA, Singh JA.

J Rheumatol. 2015 Oct;42(10):1976-1981. doi: 10.3899/jrheum.141200. Epub 2015 Jun 1.

PMID:
26034159

Supplemental Content

Loading ...
Support Center